Krystal Biotech (KRYS) Interest & Investment Income (2021 - 2025)
Historic Interest & Investment Income for Krystal Biotech (KRYS) over the last 5 years, with Q4 2025 value amounting to $6.9 million.
- Krystal Biotech's Interest & Investment Income fell 516.93% to $6.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $28.3 million, marking a year-over-year decrease of 433.73%. This contributed to the annual value of $28.2 million for FY2025, which is 483.65% down from last year.
- Per Krystal Biotech's latest filing, its Interest & Investment Income stood at $6.9 million for Q4 2025, which was down 516.93% from $6.6 million recorded in Q3 2025.
- In the past 5 years, Krystal Biotech's Interest & Investment Income registered a high of $7.6 million during Q1 2024, and its lowest value of $30000.0 during Q2 2021.
- Moreover, its 5-year median value for Interest & Investment Income was $5.7 million (2023), whereas its average is $4.3 million.
- As far as peak fluctuations go, Krystal Biotech's Interest & Investment Income skyrocketed by 378428.57% in 2022, and later plummeted by 964.78% in 2025.
- Krystal Biotech's Interest & Investment Income (Quarter) stood at $70000.0 in 2021, then surged by 3784.29% to $2.7 million in 2022, then skyrocketed by 172.49% to $7.4 million in 2023, then dropped by 2.35% to $7.2 million in 2024, then dropped by 5.17% to $6.9 million in 2025.
- Its last three reported values are $6.9 million in Q4 2025, $6.6 million for Q3 2025, and $7.5 million during Q2 2025.